Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
5,300
Employees5,300
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
5,300
Employees5,300

GMED Key Statistics

Market cap
12.46B
Market cap12.46B
Price-Earnings ratio
29.90
Price-Earnings ratio29.90
Dividend yield
Dividend yield
Average volume
1.44M
Average volume1.44M
High today
$95.00
High today$95.00
Low today
$90.81
Low today$90.81
Open price
$94.63
Open price$94.63
Volume
1.32M
Volume1.32M
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

The current Globus Medical(GMED) stock price is $90.81, with a market capitalization of 12.46B. The stock trades at a price-to-earnings (P/E) ratio of 29.90.

On 2026-01-25, Globus Medical(GMED) stock traded between a low of $90.81 and a high of $95.00. Shares are currently priced at $90.81, which is 0.0% above the low and -4.4% below the high.

Globus Medical(GMED) shares are trading with a volume of 1.32M, against a daily average of 1.44M.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $101.40 at its peak.

During the past year, Globus Medical(GMED) stock moved between $51.79 at its lowest and $101.40 at its peak.

GMED News

Simply Wall St 9h
Is Globus Medical Pricing Reflect Its DCF Upside And Mixed P/E Signals?

If you are wondering whether Globus Medical is fairly priced right now or if the market is missing something, you are not alone. The share price recently close...

Is Globus Medical Pricing Reflect Its DCF Upside And Mixed P/E Signals?
Simply Wall St 3d
Globus Medical Valuation Check After Updated Guidance And NuVasive Synergy Outlook

Advertisement Why Globus Medical’s latest guidance matters for shareholders Globus Medical (GMED) has put fresh numbers on the table, outlining expected sales...

Globus Medical Valuation Check After Updated Guidance And NuVasive Synergy Outlook
Simply Wall St 6d
Globus Medical’s Higher 2025–2026 Revenue Guidance Might Change The Case For Investing In Globus Medical

In early January 2026, Globus Medical, Inc. issued updated guidance, forecasting fourth-quarter 2025 sales of approximately US$823.2 million and full-year 2025...

Globus Medical’s Higher 2025–2026 Revenue Guidance Might Change The Case For Investing In Globus Medical

Analyst ratings

56%

of 16 ratings
Buy
56.3%
Hold
37.5%
Sell
6.3%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.